Advanced search
2 files | 16.65 MB Add to list

Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer

(2020) BIOMATERIALS. 257.
Author
Organization
Abstract
Radiotherapy (RT) is an essential treatment modality for several types of cancer. Despite its therapeutic potential, RT is frequently insufficient to overcome the immunosuppressive nature of the tumor microenvironment, failing to control tumor metastases. Innovative immunomodulatory strategies, like immunostimulatory biomaterials could be used to boost the immunogenic effects of RT. Herein, we addressed the synergistic potential of immunostimulatory chitosan/poly(γ-glutamic acid) nanoparticles (Ch/γ-PGA NPs) combined with RT to induce antitumor immunity in the 4T1 orthotopic breast tumor mouse model. Non-treated animals had progressive primary tumor growth and developed splenomegaly and lung metastases. While RT decreased primary tumor burden, Ch/γ-PGA NPs-treatment decreased systemic immunosuppression and lung metastases. The combination therapy (RT + Ch/γ-PGA NPs) synergistically impaired 4T1 tumor progression, which was associated with a significant primary tumor growth and splenomegaly reduction, a decrease in the percentage of splenic immunosuppressive myeloid cells and an increase in antitumoral CD4+IFN-γ+ population. Notably, animals from the combination therapy presented less and smaller lung metastatic foci and lower levels of the systemic pro-tumor cytokines IL-3, IL-4, IL-10, and of the CCL4 chemokine, in comparison to non-treated animals. Overall, these results evidenced that Ch/γ-PGA NPs potentiate and synergize with RT, headlining their promising role as adjuvant anticancer strategies.
Keywords
Biophysics, Mechanics of Materials, Bioengineering, Biomaterials, Ceramics and Composites, Nanoparticles, Radiotherapy, Immunomodulation, Breast cancer, Combination therapy, Immunotherapy, GAMMA-GLUTAMIC ACID, TUMOR-INFILTRATING MACROPHAGES, MAMMARY-CARCINOMA 4T1, DENDRITIC CELLS, POLY(GAMMA-GLUTAMIC ACID), IMMUNE-SYSTEM, MYELOID CELLS, T-CELLS, RADIATION, IMPROVES

Downloads

  • 751-Castro et al.pdf
    • full text (Accepted manuscript)
    • |
    • open access
    • |
    • PDF
    • |
    • 7.08 MB
  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 9.57 MB

Citation

Please use this url to cite or link to this publication:

MLA
Castro, Flávia, et al. “Chitosan/γ-PGA Nanoparticles-Based Immunotherapy as Adjuvant to Radiotherapy in Breast Cancer.” BIOMATERIALS, vol. 257, 2020, doi:10.1016/j.biomaterials.2020.120218.
APA
Castro, F., Pinto, M. L., Pereira, C. L., Serre, K., Barbosa, M. A., Vermaelen, K., … Oliveira, M. J. (2020). Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer. BIOMATERIALS, 257. https://doi.org/10.1016/j.biomaterials.2020.120218
Chicago author-date
Castro, Flávia, Marta L. Pinto, Catarina L. Pereira, Karine Serre, Mário A. Barbosa, Karim Vermaelen, Fátima Gärtner, Raquel M. Gonçalves, Olivier De Wever, and Maria J. Oliveira. 2020. “Chitosan/γ-PGA Nanoparticles-Based Immunotherapy as Adjuvant to Radiotherapy in Breast Cancer.” BIOMATERIALS 257. https://doi.org/10.1016/j.biomaterials.2020.120218.
Chicago author-date (all authors)
Castro, Flávia, Marta L. Pinto, Catarina L. Pereira, Karine Serre, Mário A. Barbosa, Karim Vermaelen, Fátima Gärtner, Raquel M. Gonçalves, Olivier De Wever, and Maria J. Oliveira. 2020. “Chitosan/γ-PGA Nanoparticles-Based Immunotherapy as Adjuvant to Radiotherapy in Breast Cancer.” BIOMATERIALS 257. doi:10.1016/j.biomaterials.2020.120218.
Vancouver
1.
Castro F, Pinto ML, Pereira CL, Serre K, Barbosa MA, Vermaelen K, et al. Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer. BIOMATERIALS. 2020;257.
IEEE
[1]
F. Castro et al., “Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer,” BIOMATERIALS, vol. 257, 2020.
@article{8671451,
  abstract     = {{Radiotherapy (RT) is an essential treatment modality for several types of cancer. Despite its therapeutic potential, RT is frequently insufficient to overcome the immunosuppressive nature of the tumor microenvironment, failing to control tumor metastases. Innovative immunomodulatory strategies, like immunostimulatory biomaterials could be used to boost the immunogenic effects of RT. Herein, we addressed the synergistic potential of immunostimulatory chitosan/poly(γ-glutamic acid) nanoparticles (Ch/γ-PGA NPs) combined with RT to induce antitumor immunity in the 4T1 orthotopic breast tumor mouse model. Non-treated animals had progressive primary tumor growth and developed splenomegaly and lung metastases. While RT decreased primary tumor burden, Ch/γ-PGA NPs-treatment decreased systemic immunosuppression and lung metastases. The combination therapy (RT + Ch/γ-PGA NPs) synergistically impaired 4T1 tumor progression, which was associated with a significant primary tumor growth and splenomegaly reduction, a decrease in the percentage of splenic immunosuppressive myeloid cells and an increase in antitumoral CD4+IFN-γ+ population. Notably, animals from the combination therapy presented less and smaller lung metastatic foci and lower levels of the systemic pro-tumor cytokines IL-3, IL-4, IL-10, and of the CCL4 chemokine, in comparison to non-treated animals. Overall, these results evidenced that Ch/γ-PGA NPs potentiate and synergize with RT, headlining their promising role as adjuvant anticancer strategies.}},
  articleno    = {{120218}},
  author       = {{Castro, Flávia and Pinto, Marta L. and Pereira, Catarina L. and Serre, Karine and Barbosa, Mário A. and Vermaelen, Karim and Gärtner, Fátima and Gonçalves, Raquel M. and De Wever, Olivier and Oliveira, Maria J.}},
  issn         = {{0142-9612}},
  journal      = {{BIOMATERIALS}},
  keywords     = {{Biophysics,Mechanics of Materials,Bioengineering,Biomaterials,Ceramics and Composites,Nanoparticles,Radiotherapy,Immunomodulation,Breast cancer,Combination therapy,Immunotherapy,GAMMA-GLUTAMIC ACID,TUMOR-INFILTRATING MACROPHAGES,MAMMARY-CARCINOMA 4T1,DENDRITIC CELLS,POLY(GAMMA-GLUTAMIC ACID),IMMUNE-SYSTEM,MYELOID CELLS,T-CELLS,RADIATION,IMPROVES}},
  language     = {{eng}},
  pages        = {{15}},
  title        = {{Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer}},
  url          = {{http://doi.org/10.1016/j.biomaterials.2020.120218}},
  volume       = {{257}},
  year         = {{2020}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: